Modulation of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity by 1,5-Substituted 1H-Tetrazoles

Inhibitors of 11β-hydroxysteroid dehydrogenase (11β-HSD1) show promise as drugs to treat metabolic disease and CNS disorders such as cognitive impairment. A series of 1,5-substituted 1H-tetrazole 11β-HSD1 inhibitors has been discovered and chemically modified. Compounds are selective for 11β-HSD1 ov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Webster, Scott P., Binnie, Margaret, McConnell, Kirsty M. M., Sooy, Karen, Ward, Peter, Greaney, Michael F., Vinter, Andy, Pallin, T. David, Dyke, Hazel J., Gill, Matthew I. A., Warner, Ines, Seckl, Jonathan R., Walker, Brian R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3972730/
https://ncbi.nlm.nih.gov/pubmed/20452767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2010.04.055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados